Does Starting HRT (Hormone Replacement Therapy) After 65 Raise My Risk of Stroke, Blood Clots, or Breast Cancer?

Deciding whether to begin HRT (Hormone Replacement Therapy) after age 65 involves weighing potential benefits—like relief from hot flashes, night sweats, mood swings, and bone loss—against possible risks. Below, we summarize current evidence from credible organizations (including the North American Menopause Society and large clinical trials such as the Women’s Health Initiative) in clear, everyday language. We avoid sugar-coating but also aim to keep anxiety at bay by focusing on facts and practical steps.

---

Stroke Risk

Several studies have looked at how HRT affects stroke risk in older women:

• Women’s Health Initiative (WHI) Findings
– In the WHI, healthy post-menopausal women aged 50–79 were randomized to combined estrogen‐progestin or placebo.
– Overall, women starting HRT after age 60 showed a small increase in ischemic stroke (blockage of blood flow to the brain), roughly 1–2 extra strokes per 1,000 women per year.

• Timing Matters (“Timing Hypothesis”)
– Evidence suggests that starting HRT closer to menopause (within 10 years) may carry a lower stroke risk compared to starting later.
– For women over 65, especially more than 15 years past menopause, the relative stroke risk appears modestly higher.

• Route and Dose Influence
– Oral estrogen at higher doses can raise clotting factors in the liver, potentially increasing stroke risk.
– Low-dose regimens or transdermal patches/gels bypass the liver and may have less impact on stroke markers.

Key Takeaway: Beginning systemic HRT after 65 likely carries a slightly elevated stroke risk. If you and your doctor decide HRT is right for you, using the lowest effective dose and non-oral routes can help minimize that risk.

---

Blood Clot (Venous Thromboembolism) Risk

Blood clots—deep vein thrombosis (DVT) and pulmonary embolism (PE)—are a serious concern with hormone therapy:

• Increased Clot Risk with Oral Estrogen
– WHI data showed oral combined HRT roughly doubled the risk of VTE in women aged 50–79.
– Absolute risk remained low (about 2–4 extra cases per 1,000 women per year) but climbed with age.

• Age Amplifies Risk
– Women over 65 have naturally higher baseline clot risk. Adding oral estrogen can further raise that risk.
– Other factors—obesity, smoking, recent surgery or immobilization—compound the danger.

• Transdermal vs. Oral Estrogen
– Transdermal patches or gels deliver estrogen through the skin, avoiding the first-pass liver effect that ramps up clotting proteins.
– Observational studies suggest transdermal HRT has little to no increase in VTE risk, even in older women.

• Progestogen Choice
– Some synthetic progestins may influence clotting differently than micronized progesterone.
– Discuss progestin type with your doctor to align with your personal health profile.

Key Takeaway: Oral estrogen started after age 65 carries a measurable VTE risk. Non-oral (transdermal) HRT and lower-dose regimens can be safer alternatives when you and your healthcare provider determine HRT is needed.

---

Breast Cancer Risk

Concerns about HRT and breast cancer often shape decisions around long-term therapy, especially when starting later:

• Combined Estrogen-Progestin Therapy
– WHI reported that 5 years of combined HRT starting in women 50–79 led to about 8 extra breast cancer cases per 1,000 women over 10 years.
– Breast cancers diagnosed were more likely to be hormone-sensitive and detected at earlier stages.

• Estrogen-Only Therapy
– In women who’ve had a hysterectomy, estrogen alone did not significantly raise breast cancer risk in WHI and may even trend toward a slight decrease.
– Key point: estrogen-only HRT applies only if you have no uterus.

• Duration and Age at Start
– Risk increases with longer use. Starting after 65 for a short duration (e.g., under 3 years) carries less breast risk than continuous use over 5–10 years.
– Any HRT for more than 5 years warrants annual breast screening and careful monitoring.

• Individual Risk Factors
– Family history, genetic markers (e.g., BRCA mutations), personal health history, and lifestyle factors all play roles.
– A personalized risk assessment with your doctor is essential.

Key Takeaway: Combined HRT started after 65 modestly raises breast cancer risk over time. Estrogen-only therapy (if appropriate) and limiting duration of use can help reduce that risk. Regular screenings are a must.

---

Strategies to Manage and Mitigate Risks

If you and your healthcare provider conclude that starting HRT after 65 is worthwhile for symptom relief or bone health, consider these tactics:

1. Choose the Right Formulation
   • Transdermal estrogen patches or gels to lower clot risk
   • Micronized progesterone (if progestogen is needed)

2. Start Low, Go Slow
   • Use the minimum effective dose to control symptoms
   • Reassess every 6–12 months for ongoing need

3. Limit Duration
   • Aim for the shortest duration consistent with your goals (often under 5 years)
   • Plan a structured “trial off” to see if you still need hormones

4. Monitor Closely
   • Annual breast exams and mammograms
   • Regular blood pressure checks and cardiovascular evaluations
   • Watch for new or worsening symptoms—sudden leg swelling, unexplained headaches, or chest pain

5. Address Lifestyle Factors
   • Maintain a healthy weight, active lifestyle, and balanced diet
   • Quit smoking and limit alcohol—both independently lower breast cancer and clot risks

---

Next Steps and When to Seek Help

Choosing HRT at any age is a personal decision best made with your doctor. If you’re unsure about your symptoms or risks:

• Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker
• Gather your medical history, family history, and a list of current medications
• Discuss your goals (symptom relief, bone health, quality of life) and concerns (stroke, blood clots, cancer)

Above all, speak to a doctor about anything that could be life threatening or serious. No online tool replaces a personalized medical evaluation—especially if you experience new chest pain, sudden leg swelling, severe headache, or any alarming change in health.

---

Starting HRT (Hormone Replacement Therapy) after 65 can bring quality-of-life benefits but does involve small increases in stroke, blood-clot, and breast cancer risks. By choosing the right route, dose, and duration—and by closely monitoring your health—you and your provider can find a balanced approach that addresses symptoms safely.